Literature DB >> 7118407

Ribonuclease inhibitors from the livers of five mammalian species.

L E Burton, N P Fucci.   

Abstract

Inhibitors of neutral ribonuclease have been purified to homogeneity from beef, pig, sheep, mouse, and rat liver by affinity chromatography on Sepharose-RNase A with overall yields ranging from 60-80%. Each of the purified inhibitors presents a single band by SDS-gel electrophoresis; molecular weight estimates by SDS-gel electrophoresis and by gel filtration are ca. 50 000. Each of the inhibitors forms a complex with beef pancreatic RNase A with a molecular weight of ca. 64 000, suggestive of 1:1 binding on a molar basis. The inhibitors from liver are very similar in properties and amino acid composition to the previously isolated inhibitor from human placenta (Blackburn et al. (1977) J. Biol. Chem. 252, 5904) and beef brain (Burton et al. (1980) Int. J. Peptide Protein Res. 16, 359). Pig liver offers an alternative to human placenta as a source for an RNase inhibitor of this type (yield, ca. 8 mg/kg of tissue). Immunological similarities were examined using antiserum directed against human placental RNase inhibitor. Cross reactivity of the liver RNase inhibitors with the antiserum raised against placental RNase inhibitor ranged from 15% for mouse RNase inhibitor to as low as 2% for pig and sheep RNase inhibitor.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7118407     DOI: 10.1111/j.1399-3011.1982.tb02618.x

Source DB:  PubMed          Journal:  Int J Pept Protein Res        ISSN: 0367-8377


  7 in total

Review 1.  Ribonuclease inhibitor: structure and function.

Authors:  Kimberly A Dickson; Marcia C Haigis; Ronald T Raines
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  2005

2.  Sensitivity of monomeric and dimeric forms of bovine seminal ribonuclease to human placental ribonuclease inhibitor.

Authors:  B S Murthy; R Sirdeshmukh
Journal:  Biochem J       Date:  1992-01-15       Impact factor: 3.857

3.  Affinity chromatography of RNase inhibitor.

Authors:  M A Garcia; R J Klebe
Journal:  Mol Biol Rep       Date:  1997-11       Impact factor: 2.316

4.  Theoretical treatment of tight-binding inhibition of an enzyme. Ribonuclease inhibitor as special case.

Authors:  J M Fominaya; J M García-Segura; M Ferreras; J G Gavilanes
Journal:  Biochem J       Date:  1988-07-15       Impact factor: 3.857

5.  Template-Independent Poly(A)-Tail Decay and RNASEL as Potential Cellular Biomarkers for Prostate Cancer Development.

Authors:  Gordana Kocić; Jovan Hadzi-Djokić; Andrej Veljković; Stefanos Roumeliotis; Ljubinka Janković-Veličković; Andrija Šmelcerović
Journal:  Cancers (Basel)       Date:  2022-04-29       Impact factor: 6.575

6.  Intraspecies regulation of ribonucleolytic activity.

Authors:  R Jeremy Johnson; Luke D Lavis; Ronald T Raines
Journal:  Biochemistry       Date:  2007-10-23       Impact factor: 3.162

Review 7.  Uncoupling Molecular Testing for SARS-CoV-2 From International Supply Chains.

Authors:  Jo-Ann L Stanton; Rory O'Brien; Richard J Hall; Anastasia Chernyavtseva; Hye Jeong Ha; Lauren Jelley; Peter D Mace; Alexander Klenov; Jackson M Treece; John D Fraser; Fiona Clow; Lewis Clarke; Yongdong Su; Harikrishnan M Kurup; Vyacheslav V Filichev; William Rolleston; Lee Law; Phillip M Rendle; Lawrence D Harris; James M Wood; Thomas W Scully; James E Ussher; Jenny Grant; Timothy A Hore; Tim V Moser; Rhodri Harfoot; Blair Lawley; Miguel E Quiñones-Mateu; Patrick Collins; Richard Blaikie
Journal:  Front Public Health       Date:  2022-01-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.